EU IVDR Implementation Workshop

The EU IVDR establishes a new risk-based classification system, stricter postmarket surveillance, upgraded dossiers for all products and notified body review of previously self-declared products, greater clinical evidence requirements, and emphasis on transparency & traceability, including reporting risk, clinical, safety, and performance data to a publicly available database. It will require massive investments of time and money, and changes in organizational structure. Plan now!